Multimodal Randomized Functional MR Imaging of the Effects of Methylene Blue in the Human Brain (2016)

Peer-Reviewed Study · Rodriguez P; Zhou W; Barrett DW; Altmeyer W; Gutierrez JE; Li J; Lancaster JL; Gonzalez-Lima F; Duong TQ · June 28, 2016

Rodriguez P et al., 2016-06-28: Randomized, double-blind, placebo-controlled fMRI trial (26 healthy adults, USA). Single oral dose of 280 mg USP methylene blue, described by the authors as approximately 4 mg/kg and explicitly scaled as 4 mg/kg for a 70 kg adult; imaging and cognitive testing 1 hour after dosing.

13 participants (the methylene blue group) were randomized to receive 280 mg (approximately 4 mg/kg) of oral U.S. Pharmacopeia-grade methylene blue

Rodriguez P et al., 2016-06-28: Randomized, double-blind, placebo-controlled fMRI trial (26 healthy adults, USA). Single oral dose of 280 mg USP methylene blue, described by the authors as approximately 4 mg/kg and explicitly scaled as 4 mg/kg for a 70 kg adult; imaging and cognitive testing 1 hour after dosing. Study type: randomized trial.